Strategic Wealth Investment Group’s Serina Therapeutics SER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$37.5K Buy
2,769
+136
+5% +$2.5K 0.01% 129
2023
Q3
$63K Buy
2,633
+299
+13% +$7.91K 0.01% 99
2023
Q2
$73.3K Sell
2,334
-112
-5% -$2.4K 0.01% 123
2023
Q1
$57K Sell
2,446
-12
-0.5% -$276 0.01% 128
2022
Q4
$60.5K Buy
2,458
+126
+5% +$2.65K 0.01% 117
2022
Q3
$46K Sell
2,332
-683
-23% -$15.4K 0.01% 109
2022
Q2
$61K Sell
3,015
-261
-8% -$7.05K 0.02% 131
2022
Q1
$98K Buy
3,276
+84
+3% +$2.39K 0.02% 98
2021
Q4
$122K Buy
3,192
+549
+21% +$14.8K 0.03% 86
2021
Q3
$87K Buy
2,643
+790
+43% +$33.1K 0.03% 85
2021
Q2
$101K Buy
1,853
+171
+10% +$8.58K 0.04% 84
2021
Q1
$96K Buy
1,682
+104
+7% +$7.28K 0.05% 74
2020
Q4
$84K Sell
1,578
-52
-3% -$3K 0.05% 79
2020
Q3
$46K Buy
1,630
+289
+22% +$10.3K 0.03% 85
2020
Q2
$45K Buy
+1,341
New +$39.5K 0.04% 79

Other funds holding SER

Strategic Wealth Investment Group's SER Position: Q4 2023 in Review

Strategic Wealth Investment Group increased its Serina Therapeutics (SER) stake by 5.2% in Q4 2023, buying an estimated $2.5K and bringing the position to 2,769 shares worth $37.5K. The position accounts for 0.01% of the portfolio, ranked #129.

Strategic Wealth Investment Group first reported a position in SER in Q2 2020 and has held it in 15 quarters since. The position peaked at $122K in Q4 2021. 34 funds tracked by Wall St. Rank hold SER as of Q4 2023.

  • Strategic Wealth Investment Group held 2,769 shares of Serina Therapeutics worth $37.5K as of Q4 2023.
  • Strategic Wealth Investment Group bought 136 Serina Therapeutics shares in Q4 2023, an estimated $2.5K.
  • Serina Therapeutics made up 0.01% of Strategic Wealth Investment Group's portfolio in Q4 2023, its #129 holding.
  • Strategic Wealth Investment Group first reported a position in Serina Therapeutics in Q2 2020 and has held it in 15 quarters since.
  • Strategic Wealth Investment Group's Serina Therapeutics position peaked at $122K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Serina Therapeutics as of Q4 2023.

Based on Strategic Wealth Investment Group's 13F filing for Q4 2023, filed 16 Jan 2024.